Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Aug 15;98(4):1047–1054. doi: 10.1172/JCI118865

Role of cysteine proteases and protease inhibitors in gastric mucosal damage induced by ethanol or ammonia in the rat.

L Nagy 1, S Kusstatscher 1, P V Hauschka 1, S Szabo 1
PMCID: PMC507521  PMID: 8770878

Abstract

Since recent studies suggest an imbalance between cathepsin B and its tissue protease inhibitors (PI) in the pathogenesis of acute and chronic diseases, we tested the hypothesis that release of activated cysteine proteases (P) such as cathepsins B, H, and L might play a role in the pathogenesis of gastric hemorrhagic mucosal lesions (HML) induced by ethanol (E) or ammonia (A). Anesthetized rats received 1 ml of 50% E or 1% A solution intragastrically for 1 min during in situ gastric luminal perfusion. Rapid activation and release of cathepsins B, L, and H into the luminal perfusate preceded the formation of HML quantified by planimetry. Mucosal presence and activity of cysteine PI and cathepsin B have also been investigated in the pathogenesis of chemically induced HML. We extracted and partially isolated acid and thermostable inhibitors of cathepsin B in the gastric mucosa, and found rapid inactivation of PI and activation of cathepsin B in the early phase of E- or A-induced HML. Negative correlations were found between P and PI activities by E or A solutions. Both the activation of cathepsins B, L, and H and the development of E-induced HML were prevented by pretreatment with the sulfhydryl alkylator N-ethylmaleimide. These results suggest that cysteine P may be activated in the rat stomach after E or A exposure, and cysteine P may have a role in the pathogenesis of E- or A-induced gastric HML. Endogenous PI may also participate in the mechanisms of gastric mucosal lesions and gastroprotection.

Full Text

The Full Text of this article is available as a PDF (447.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baici A., Lang A. Cathepsin B secretion by rabbit articular chondrocytes: modulation by cycloheximide and glycosaminoglycans. Cell Tissue Res. 1990 Mar;259(3):567–573. doi: 10.1007/BF01740785. [DOI] [PubMed] [Google Scholar]
  2. Baricos W. H., Shah S. V. Proteolytic enzymes as mediators of glomerular injury. Kidney Int. 1991 Aug;40(2):161–173. doi: 10.1038/ki.1991.196. [DOI] [PubMed] [Google Scholar]
  3. Barrett A. J. Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates. Biochem J. 1980 Jun 1;187(3):909–912. doi: 10.1042/bj1870909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  5. Buttle D. J., Abrahamson M., Burnett D., Mort J. S., Barrett A. J., Dando P. M., Hill S. L. Human sputum cathepsin B degrades proteoglycan, is inhibited by alpha 2-macroglobulin and is modulated by neutrophil elastase cleavage of cathepsin B precursor and cystatin C. Biochem J. 1991 Jun 1;276(Pt 2):325–331. doi: 10.1042/bj2760325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chung S. M., Kawai K. Protease activities in gastric cancer tissues. Clin Chim Acta. 1990 Aug 15;189(2):205–210. doi: 10.1016/0009-8981(90)90093-8. [DOI] [PubMed] [Google Scholar]
  7. Gubbins G. P., Moritz T. E., Marsano L. S., Talwalkar R., McClain C. J., Mendenhall C. L. Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: the ammonia hypothesis revisited. The Veterans Administration Cooperative Study Group No. 275. Am J Gastroenterol. 1993 Nov;88(11):1906–1910. [PubMed] [Google Scholar]
  8. Hiwasa T., Sakiyama S., Yokoyama S., Ha J. M., Noguchi S., Bando Y., Kominami E., Katunuma N. Degradation of epidermal growth factor receptors by cathepsin L-like protease: inhibition of the degradation by c-Ha-ras gene products. FEBS Lett. 1988 Jun 20;233(2):367–370. doi: 10.1016/0014-5793(88)80462-9. [DOI] [PubMed] [Google Scholar]
  9. Ishii H., Kuboki M., Fujii J., Hiraishi S., Kazama M. Thiolprotease inhibitor, EST, can inhibit thrombin-induced platelet activation. Thromb Res. 1990 Mar 15;57(6):847–861. doi: 10.1016/0049-3848(90)90152-3. [DOI] [PubMed] [Google Scholar]
  10. Janoff A., Carp H. Proteases, antiproteases, and oxidants: pathways of tissue injury during inflammation. Monogr Pathol. 1982;(23):62–82. [PubMed] [Google Scholar]
  11. Khar A. Activation of collagenase production in a rat macrophage-like cell line. Biochem Int. 1986 Oct;13(4):565–570. [PubMed] [Google Scholar]
  12. László A., Sohár I., Karácsonyi S., Petri A., Troján I. Activities of serum cathepsin (B, H and L) and metalloproteinase (MMP7-ase) in patients with gastrointestinal and bronchial malignant tumours. Acta Med Hung. 1990;47(1-2):107–109. [PubMed] [Google Scholar]
  13. Ohe K., Ueno N., Yokoya H., Miyoshi A. The activation of pepsinogen inside the gastric mucosa caused by the hydrogen ion back diffusion during the course of aspirin ulceration. Hiroshima J Med Sci. 1979 Mar;28(1):1–11. [PubMed] [Google Scholar]
  14. Polgár L. The different mechanisms of protease action have a basic feature in common: proton transfer from the attacking nucleophile to the substrate leaving group. Acta Biochim Biophys Hung. 1988;23(3-4):207–213. [PubMed] [Google Scholar]
  15. Samloff I. M. Peptic ulcer: the many proteinases of aggression. Gastroenterology. 1989 Feb;96(2 Pt 2 Suppl):586–595. doi: 10.1016/s0016-5085(89)80054-x. [DOI] [PubMed] [Google Scholar]
  16. Schwartz W. N., Barrett A. J. Human cathepsin H. Biochem J. 1980 Nov 1;191(2):487–497. doi: 10.1042/bj1910487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Szabo S. Mechanisms of gastric mucosal injury and protection. J Clin Gastroenterol. 1991;13 (Suppl 2):S21–S34. [PubMed] [Google Scholar]
  18. Szabo S., Nagy L., Plebani M. Glutathione, protein sulfhydryls and cysteine proteases in gastric mucosal injury and protection. Clin Chim Acta. 1992 Mar 13;206(1-2):95–105. doi: 10.1016/0009-8981(92)90010-n. [DOI] [PubMed] [Google Scholar]
  19. Szabo S., Trier J. S., Brown A., Schnoor J. Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology. 1985 Jan;88(1 Pt 2):228–236. doi: 10.1016/s0016-5085(85)80176-1. [DOI] [PubMed] [Google Scholar]
  20. Tarnawski A., Hollander D., Stachura J., Krause W. J., Gergely H. Prostaglandin protection of the gastric mucosa against alcohol injury--a dynamic time-related process. Role of the mucosal proliferative zone. Gastroenterology. 1985 Jan;88(1 Pt 2):334–352. doi: 10.1016/s0016-5085(85)80188-8. [DOI] [PubMed] [Google Scholar]
  21. Trier J. S., Szabo S., Allan C. H. Ethanol-induced damage to mucosal capillaries of rat stomach. Ultrastructural features and effects of prostaglandin F2 beta and cysteamine. Gastroenterology. 1987 Jan;92(1):13–22. doi: 10.1016/0016-5085(87)90834-1. [DOI] [PubMed] [Google Scholar]
  22. Yamashita M., Konagaya S. High activities of cathepsins B, D, H, and L in the white muscle of chum salmon in spawning migration. Comp Biochem Physiol B. 1990;95(1):149–152. doi: 10.1016/0305-0491(90)90262-r. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES